Prostate cancer presents an immunosuppressive microenvironment, including lack of CD8+ lymphocytes’ infiltration, downregulation of major histocompatibility complex (MHC) expression, and higher expression of programmed cell death-ligand 1 (PD-L1) [4,5,6]. Here, CD274 is linked to prostate cancer.